Pectin nanocoating reduces proinflammatory fibroblast response to bacteria

Research output: Contribution to journalArticle

Standard

Pectin nanocoating reduces proinflammatory fibroblast response to bacteria. / Mieszkowska, A; Folkert, J; Gaber, T; Miksch, K; Gurzawska, K.

In: Journal of Biomedical Materials Research Part A, 07.08.2017.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{aeecb65c1e9040949652c436910ba506,
title = "Pectin nanocoating reduces proinflammatory fibroblast response to bacteria",
abstract = "Implant failures are primarily related to bacterial infections and inflammation. Nanocoating of implant devices with organic molecules is a method used for improving their integration into host tissues and limiting inflammation. Bioengineered plant-derived rhamnogalacturonan-Is (RG-Is) from pectins improve tissue regeneration and exhibit anti-inflammatory properties. Therefore, the aim of this study is to evaluate the in vitro effect of RG-I nanocoating on human gingival primary fibroblast (HGF) activity and proinflammatory response following Porphyromonas gingivalis (P. gingivalis) infection. Infected HGFs were incubated on tissue culture polystyrene (TCPS) plates coated with unmodified RG-I isolated from potato pectin (PU) and dearabinanated RG-I (PA). HGF morphology, proliferation, metabolic activity, and expression of genes responsible for extracellular matrix (ECM) turnover and proinflammatory response were examined. Following the P. gingivalis infection, PU and PA significantly promoted HGF proliferation and metabolic activity. Moreover, gene expression levels of IL1B, IL8, TNFA, and MMP2 decreased in the infected cells cultured on PU and PA, whereas the expression of COL1A1, FN1, and FGFR1 was upregulated. The results indicate that RG-Is are promising candidates for nanocoating of an implant surface, can reduce inflammation, and enhance implant integration, particularly in medically compromised patients with chronic inflammatory diseases such as periodontitis and rheumatoid arthritis. This article is protected by copyright. All rights reserved.",
keywords = "inflammation, fibroblast, dental implants, rhamnogalacturonan-I, nanocoating",
author = "A Mieszkowska and J Folkert and T Gaber and K Miksch and K Gurzawska",
note = "{\textcopyright} 2017 Wiley Periodicals, Inc.",
year = "2017",
month = aug,
day = "7",
doi = "10.1002/jbm.a.36170",
language = "English",
journal = "Journal of Biomedical Materials Research Part A",
issn = "1549-3296",
publisher = "Wiley",

}

RIS

TY - JOUR

T1 - Pectin nanocoating reduces proinflammatory fibroblast response to bacteria

AU - Mieszkowska, A

AU - Folkert, J

AU - Gaber, T

AU - Miksch, K

AU - Gurzawska, K

N1 - © 2017 Wiley Periodicals, Inc.

PY - 2017/8/7

Y1 - 2017/8/7

N2 - Implant failures are primarily related to bacterial infections and inflammation. Nanocoating of implant devices with organic molecules is a method used for improving their integration into host tissues and limiting inflammation. Bioengineered plant-derived rhamnogalacturonan-Is (RG-Is) from pectins improve tissue regeneration and exhibit anti-inflammatory properties. Therefore, the aim of this study is to evaluate the in vitro effect of RG-I nanocoating on human gingival primary fibroblast (HGF) activity and proinflammatory response following Porphyromonas gingivalis (P. gingivalis) infection. Infected HGFs were incubated on tissue culture polystyrene (TCPS) plates coated with unmodified RG-I isolated from potato pectin (PU) and dearabinanated RG-I (PA). HGF morphology, proliferation, metabolic activity, and expression of genes responsible for extracellular matrix (ECM) turnover and proinflammatory response were examined. Following the P. gingivalis infection, PU and PA significantly promoted HGF proliferation and metabolic activity. Moreover, gene expression levels of IL1B, IL8, TNFA, and MMP2 decreased in the infected cells cultured on PU and PA, whereas the expression of COL1A1, FN1, and FGFR1 was upregulated. The results indicate that RG-Is are promising candidates for nanocoating of an implant surface, can reduce inflammation, and enhance implant integration, particularly in medically compromised patients with chronic inflammatory diseases such as periodontitis and rheumatoid arthritis. This article is protected by copyright. All rights reserved.

AB - Implant failures are primarily related to bacterial infections and inflammation. Nanocoating of implant devices with organic molecules is a method used for improving their integration into host tissues and limiting inflammation. Bioengineered plant-derived rhamnogalacturonan-Is (RG-Is) from pectins improve tissue regeneration and exhibit anti-inflammatory properties. Therefore, the aim of this study is to evaluate the in vitro effect of RG-I nanocoating on human gingival primary fibroblast (HGF) activity and proinflammatory response following Porphyromonas gingivalis (P. gingivalis) infection. Infected HGFs were incubated on tissue culture polystyrene (TCPS) plates coated with unmodified RG-I isolated from potato pectin (PU) and dearabinanated RG-I (PA). HGF morphology, proliferation, metabolic activity, and expression of genes responsible for extracellular matrix (ECM) turnover and proinflammatory response were examined. Following the P. gingivalis infection, PU and PA significantly promoted HGF proliferation and metabolic activity. Moreover, gene expression levels of IL1B, IL8, TNFA, and MMP2 decreased in the infected cells cultured on PU and PA, whereas the expression of COL1A1, FN1, and FGFR1 was upregulated. The results indicate that RG-Is are promising candidates for nanocoating of an implant surface, can reduce inflammation, and enhance implant integration, particularly in medically compromised patients with chronic inflammatory diseases such as periodontitis and rheumatoid arthritis. This article is protected by copyright. All rights reserved.

KW - inflammation

KW - fibroblast

KW - dental implants

KW - rhamnogalacturonan-I

KW - nanocoating

U2 - 10.1002/jbm.a.36170

DO - 10.1002/jbm.a.36170

M3 - Article

C2 - 28782183

JO - Journal of Biomedical Materials Research Part A

JF - Journal of Biomedical Materials Research Part A

SN - 1549-3296

ER -